Ballad Health

Johnson City, Tennessee 37604

0 studies enrolling now · 3 studies all time

What they study most

Chemoradiotherapy-Induced Severe Oral Mucositis, Oral Mucositis

Studies at this site

• RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer — Running, not enrolling
• Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers — Completed
• Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer. — Stopped early